Terns Pharmaceuticals(TERN) - 2025 Q1 - Quarterly Report

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 (Exact Name of Registrant as Specified in its Charter) FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2025 Delaware 98-1448275 (State or other jurisdiction of incorporation or organization) 1065 East Hillsdale Blvd., Suite 100 Foster City, California 94404 (Address of principal executive offices) (Zip Code) (I.R.S. Employer Identificat ...